{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:36:54Z","timestamp":1794353814819,"version":"4.9.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.euroneuro.2014.05.013","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T12:33:58Z","timestamp":1401712438000},"page":"1210-1221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder"],"prefix":"10.1016","volume":"24","author":[{"given":"Leila","family":"Jahangard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Soroush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Haghighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ghaleiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafez","family":"Bajoghli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Holsboer-Trachsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2175-2765","authenticated-orcid":false,"given":"Serge","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2014.05.013_bib1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1399-5618.2006.00363.x","article-title":"Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial","volume":"8","author":"Akhondzadeh","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2014.05.013_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"issue":"2","key":"10.1016\/j.euroneuro.2014.05.013_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0091-3057(89)90515-7","article-title":"Hyperuricemia and locomotor activity in developing rats","volume":"33","author":"Barrera","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2014.05.013_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5694\/j.1326-5377.1949.tb36912.x","article-title":"Lithium salts in the treatment of psychotic excitement","volume":"2","author":"Cade","year":"1949","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.euroneuro.2014.05.013_bib5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.psychres.2009.07.012","article-title":"Increased risk of gout among patients with bipolar disorder: a nationwide population-based study","volume":"180","author":"Chung","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2014.05.013_bib6","first-page":"195","article-title":"Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder","volume":"22","author":"De Berardis","year":"2008","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.euroneuro.2014.05.013_bib7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1399-5618.2012.01001.x","article-title":"Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot study","volume":"14","author":"Fan","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2014.05.013_bib8","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.4088\/JCP.v67n0806","article-title":"The economic impact of bipolar disorder in an employed population from an employer perspective","volume":"67","author":"Gardner","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.05.013_bib9","series-title":"ECDEU Assessment for Psychopharmacology, Revised Edition","author":"Guy","year":"1976"},{"key":"10.1016\/j.euroneuro.2014.05.013_bib10","first-page":"83","article-title":"Serum levels of sodium valproate in patients suffering from bipolar disorders: comparing acute and maintenance phases of mania","volume":"46","author":"Kamalinia","year":"2013","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.euroneuro.2014.05.013_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2008.09.014","article-title":"A review of panic and suicide in bipolar disorder: does comorbidity increase risk?","volume":"115","author":"Kilbane","year":"2009","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.euroneuro.2014.05.013_bib12","unstructured":"Kraepelin E. 1913. Manic-depressive insanity and paranoia (R. Mary Barclay, Trans.), In: George M., Robertson E., Livingstone S., Edinburgh (Eds.), Text-Book of Psychiatry: Endogenous Dementias, vol. iii, part ii, eighth German edition, Chicago Medical Book Company, Chicago, 1921 ([\u00dcbersetzung von Kapitel XI \u201cDas manisch-depressive Irresein\u201d aus 1913a und von Kapitel XIV \u201cDie Verr\u00fccktheit (Paranoia)\u201d aus 1915a in englischer Sprache]. Psychiatrie. Ein Lehrbuch f\u00fcr Studierende und \u00c4rzte. Achte, vollst\u00e4ndig umgearbeitete Auflage. III. Band. Klinische Psychiatrie. II. Teil. Barth Verlag, Leipzig. [vgl. 1909a, 1910a, 1915a]."},{"key":"10.1016\/j.euroneuro.2014.05.013_bib13","first-page":"17","article-title":"Brunstein MG.Involvement of adenosine in the neurobiology of schizophrenia and its therapeutic implications","volume":"2006","author":"Lara","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.05.013_bib14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1100\/tsw.2010.65","article-title":"New therapeutic targets for mood disorders","volume":"10","author":"Machado-Vieira","year":"2010","journal-title":"Sci. World J."},{"issue":"5","key":"10.1016\/j.euroneuro.2014.05.013_bib15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/JCP.0b013e318268391d","article-title":"Purinergic system in the treatment of bipolar disorder: uric acid levels as a screening test in mania","volume":"32","author":"Machado-Vieira","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.05.013_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00004714-200112000-00017","article-title":"Therapeutic efficacy of allopurinol in mania associated with hyperuricemia","volume":"21","author":"Machado-Vieira","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.05.013_bib17","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v69n0806","article-title":"Double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.05.013_bib18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/da.20800","article-title":"Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments","volume":"28","author":"Machado-Vieira","year":"2011","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.euroneuro.2014.05.013_bib19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/jcbfm.2010.109","article-title":"Neuroprotective signaling pathways are modulated by adenosine in the anoxia tolerant turtle","volume":"31","author":"Nayak","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.euroneuro.2014.05.013_bib20","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.163.2.217","article-title":"Predictors of recurrence in bipolar disorder: primary outcomes from the systematic treatment enhancement program for bipolar disorder (STEP-BD)","volume":"163","author":"Perlis","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.05.013_bib21","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1176\/appi.ajp.2008.08010077","article-title":"Sleep disturbance in bipolar disorder: therapeutic implications","volume":"165","author":"Plante","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.05.013_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.smrv.2010.06.005","article-title":"Adenosine, energy metabolism and sleep homeostasis","volume":"15","author":"Porkka-Heiskanen","year":"2011","journal-title":"Sleep Med. Rev."},{"issue":"6","key":"10.1016\/j.euroneuro.2014.05.013_bib23","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.pnpbp.2010.02.027","article-title":"Increased uric acid levels in drug-na\u00efve subjects with bipolar disorder during a first manic episode","volume":"34","author":"Salvadore","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.05.013_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1517\/14728214.2010.492393","article-title":"Emerging drugs for bipolar disorder","volume":"15","author":"Sanches","year":"2010","journal-title":"Exp. Opin. Emerg. Drugs"},{"issue":"Suppl. 20","key":"10.1016\/j.euroneuro.2014.05.013_bib25","first-page":"S22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.05.013_bib26","first-page":"535","article-title":"Adenosine receptors and neurological disease: neuroprotection and neurodegeneration","volume":"193","author":"Stone","year":"2009"},{"key":"10.1016\/j.euroneuro.2014.05.013_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.arcmed.2006.10.010","article-title":"Allopurinol as adjunctive therapy in intractable epilepsy: a double blind and placebo-controlled trial","volume":"38","author":"Togha","year":"2007","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.euroneuro.2014.05.013_bib28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/bdi.12202","article-title":"Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and\/or antipsychotic agents in manic patients with bipolar disorder","volume":"16","author":"Weiser","year":"2014","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.euroneuro.2014.05.013_bib29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14001631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14001631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T12:15:38Z","timestamp":1597925738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X14001631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0924977X14001631"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.05.013","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}